Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105272793B reveals iridium-catalyzed aryl hydrazone synthesis using alcohols. Offers greener, cost-effective alternative to aldehyde condensation for pharmaceutical intermediates.
Patent CN102766098B details a novel synthesis route for 4-oxo quinolone compounds offering improved purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN106045883A reveals a novel metal-chelation route for Fmoc-Asp-OtBu, offering significant cost reduction and enhanced supply chain reliability for peptide synthesis.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN103923024B details water based recrystallization improving purity and yield reducing solvent toxicity for scalable acipimox manufacturing supply chains
Patent CN103242432A reveals a novel high-yield route for Phosphoramidon synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for this critical biochemical reagent.
Patent CN109678707B reveals a robust 4-step synthesis for D3-Salbutamol. Achieve >98% isotopic purity for food safety testing with cost-effective scalable methods.
Novel 4-step route for D3-salbutamol from ethyl salicylate. >98% purity and isotope abundance for food safety testing standards.
Advanced synthesis route for Lorcaserin intermediate offering cost reduction and scalability for pharmaceutical manufacturing supply chains globally.
Novel patent CN121318680A enables high-yield Bexagliflozin intermediate production with reduced costs and supply chain reliability for global buyers.
Patent CN116217633B details chemical synthesis avoiding enzymes. Enables scalable production and cost reduction for nutritional ingredient supply chains.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Novel regioselective protection strategy for >99% pure amino sugar phosphates, offering scalable manufacturing and simplified purification for pharmaceutical intermediates.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Patent CN115677587B enables high-purity antiviral intermediate production. Safe scalable process ensures reliable supply chain and significant cost efficiency.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Novel oxycodone synthesis uses ammonia treatment for copper removal. Enhances purity and scalability for pharmaceutical intermediate supply chains globally.
Novel two-step synthesis of (5-fluoropyrimidin-4-yl) methanol via oxidation and dechlorination. Offers streamlined manufacturing and cost reduction for API intermediates.